Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79.6M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
+165K
-
Total reported value, excl. options
-
$46M
-
Value change
-
+$411K
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$2.49
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q3 2024
33 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 79.6M outstanding shares and own 23.21% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.29M shares), ARMISTICE CAPITAL, LLC (2.36M shares), VANGUARD GROUP INC (1.57M shares), Schonfeld Strategic Advisors LLC (1.5M shares), Zimmer Partners, LP (1.43M shares), SPHERA FUNDS MANAGEMENT LTD. (1.3M shares), Woodline Partners LP (843K shares), Nantahala Capital Management, LLC (600K shares), Alyeska Investment Group, L.P. (500K shares), and Ensign Peak Advisors, Inc (443K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.